Literature DB >> 27439152

Geographic Clusters of Basal Cell Carcinoma in a Northern California Health Plan Population.

G Thomas Ray1, Martin Kulldorff2, Maryam M Asgari3.   

Abstract

Importance: Rates of skin cancer, including basal cell carcinoma (BCC), the most common cancer, have been increasing over the past 3 decades. A better understanding of geographic clustering of BCCs can help target screening and prevention efforts. Objective: Present a methodology to identify spatial clusters of BCC and identify such clusters in a northern California population. Design, Setting, and Participants: This retrospective study used a BCC registry to determine rates of BCC by census block group, and used spatial scan statistics to identify statistically significant geographic clusters of BCCs, adjusting for age, sex, and socioeconomic status. The study population consisted of white, non-Hispanic members of Kaiser Permanente Northern California during years 2011 and 2012. Main Outcomes and Measures: Statistically significant geographic clusters of BCC as determined by spatial scan statistics.
Results: Spatial analysis of 28 408 individuals who received a diagnosis of at least 1 BCC in 2011 or 2012 revealed distinct geographic areas with elevated BCC rates. Among the 14 counties studied, BCC incidence ranged from 661 to 1598 per 100 000 person-years. After adjustment for age, sex, and neighborhood socioeconomic status, a pattern of 5 discrete geographic clusters emerged, with a relative risk ranging from 1.12 (95% CI, 1.03-1.21; P = .006) for a cluster in eastern Sonoma and northern Napa Counties to 1.40 (95% CI, 1.15-1.71; P < .001) for a cluster in east Contra Costa and west San Joaquin Counties, compared with persons residing outside that cluster. Conclusions and Relevance: In this study of a northern California population, we identified several geographic clusters with modestly elevated incidence of BCC. Knowledge of geographic clusters can help inform future research on the underlying etiology of the clustering including factors related to the environment, health care access, or other characteristics of the resident population, and can help target screening efforts to areas of highest yield.

Entities:  

Mesh:

Year:  2016        PMID: 27439152      PMCID: PMC6333304          DOI: 10.1001/jamadermatol.2016.2536

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  23 in total

1.  Socioeconomic status and non-melanoma skin cancer: a nationwide cohort study of incidence and survival in Denmark.

Authors:  M Steding-Jessen; F Birch-Johansen; A Jensen; J Schüz; S K Kjær; S O Dalton
Journal:  Cancer Epidemiol       Date:  2010-07-17       Impact factor: 2.984

2.  The development of a standardized neighborhood deprivation index.

Authors:  Lynne C Messer; Barbara A Laraia; Jay S Kaufman; Janet Eyster; Claudia Holzman; Jennifer Culhane; Irma Elo; Jessica G Burke; Patricia O'Campo
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

3.  Is sunlight important to melanoma causation?

Authors:  Margaret A Tucker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03-04       Impact factor: 4.254

4.  The objective assessment of lifetime cumulative ultraviolet exposure for determining melanoma risk.

Authors:  Zaria Tatalovich; John P Wilson; Thomas Mack; Ying Yan; Myles Cockburn
Journal:  J Photochem Photobiol B       Date:  2006-09-11       Impact factor: 6.252

5.  Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995.

Authors:  A Hannuksela-Svahn; E Pukkala; J Karvonen
Journal:  Arch Dermatol       Date:  1999-07

Review 6.  The effect of socioeconomic factors on incidence, stage at diagnosis and survival of cutaneous melanoma.

Authors:  Carlos A Reyes Ortiz; James S Goodwin; Jean L Freeman
Journal:  Med Sci Monit       Date:  2005-04-28

Review 7.  Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force.

Authors:  Tracy Wolff; Eric Tai; Therese Miller
Journal:  Ann Intern Med       Date:  2009-02-03       Impact factor: 25.391

8.  Geographic variation and risk of skin cancer in US women. Differences between melanoma, squamous cell carcinoma, and basal cell carcinoma.

Authors:  Abrar A Qureshi; Francine Laden; Graham A Colditz; David J Hunter
Journal:  Arch Intern Med       Date:  2008-03-10

9.  The geographic distribution of melanoma incidence in Massachusetts, adjusted for covariates.

Authors:  Laurie M DeChello; T Joseph Sheehan
Journal:  Int J Health Geogr       Date:  2006-08-02       Impact factor: 3.918

10.  Geovisual analytics to enhance spatial scan statistic interpretation: an analysis of U.S. cervical cancer mortality.

Authors:  Jin Chen; Robert E Roth; Adam T Naito; Eugene J Lengerich; Alan M Maceachren
Journal:  Int J Health Geogr       Date:  2008-11-07       Impact factor: 3.918

View more
  4 in total

1.  Spatial clusters of cancer incidence: analyzing 1940 census data linked to 1966-2017 cancer records.

Authors:  Claire L Leiser; Marissa Taddie; Rachael Hemmert; Rebecca Richards Steed; James A VanDerslice; Kevin Henry; Jacob Ambrose; Brock O'Neil; Ken R Smith; Heidi A Hanson
Journal:  Cancer Causes Control       Date:  2020-04-22       Impact factor: 2.506

Review 2.  Research Techniques Made Simple: An Introduction to Use and Analysis of Big Data in Dermatology.

Authors:  Mackenzie R Wehner; Katherine A Levandoski; Martin Kulldorff; Maryam M Asgari
Journal:  J Invest Dermatol       Date:  2017-08       Impact factor: 8.551

3.  Geographical Disparity and Associated Factors of COPD Prevalence in China: A Spatial Analysis of National Cross-Sectional Study.

Authors:  Ning Wang; Shu Cong; Jing Fan; Heling Bao; Baohua Wang; Ting Yang; Yajing Feng; Yang Liu; Linhong Wang; Chen Wang; Wenbiao Hu; Liwen Fang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-02-13

4.  Spatial epidemiology of skin cancer in Iran: separating sun-exposed and non-sun-exposed parts of the body.

Authors:  Behzad Kiani; Parinaz Tabari; Alireza Mohammadi; Sayyed Mostafa Mostafavi; Mohsen Moghadami; Mitra Amini; Abbas Rezaianzadeh
Journal:  Arch Public Health       Date:  2022-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.